Still, the metastatic progression of the disease is frequently associated with complete loss of PTEN in prostate tumor cells50, which has been demonstrated to counteract Ca2+-dependent cell death by favoring the proteasome degradation of IP3R39. This evidence concerns the gene PTEN and prostate neoplasm.